Castle Biosciences Inc (CSTL)
Latest financial period: June 30, 2026
Filed with the SEC: July 30, 2026
Estimated earnings date: November 2, 2026
Profit #1388 of 1484 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| ROIC | -5.9% | -5.6% | -9.5% | -7.4% |
Growth #1299 of 1484 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| Sales andOCF growth | -13.2% | -13.5% | 1.9% | 7.9% |
Payout #1117 of 1484 companies
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | |
|---|---|---|---|---|
| Shareholderdistributions/ net income | 0% | 0% | 0% | 0% |
Safety #382 of 1484 companies
| Balance | Stability | |
|---|---|---|
| Equity/assets andOCF stability | 83.7% | 45.3% |
Price #1348 of 1484 companies
| Earnings | FCF | |
|---|---|---|
| Earnings andFCF yield | $-1.80 | $-0.05 |
